The global cell therapy market size reached US$ 11.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 32.1 Billion by 2028, exhibiting a growth rate (CAGR) of 17.5% during 2023-2028.
More Info:- https://www.imarcgroup.com/cell-therapy-market
2. Report Description
About IMARC Group
The International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.
3. Report Description
Report Description and Highlights
Global Cell Therapy Market Research Report:
The latest report by IMARC, titled “Cell Therapy Market: Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2023-2028” the global cell therapy market size reached US$ 11.5 Billion in
2022.
Cell therapy (CT) replaces or repairs damaged tissues and cells by using human cells as transplants. This
technology is used to develop and apply new techniques to restore function and heal tissues and
organs inflicted by aging, disease, and damage.
The therapy also improves the immune system of the body to combat cancer cells. Cell therapy can
also be used to treat numerous autoimmune and infectious diseases, urinary problems, joint damage,
spinal cord injuries, weakened immune systems, and neurological disorders.
Request Free Sample Report: https://www.imarcgroup.com/cell-therapy-market/requestsample
4. Report Description
Report Description and Highlights
Global Cell Therapy Market Trends:
The global market is majorly driven by the rising incidences of numerous chronic diseases, including cancer and
cardiovascular disorders. In line with this, the increasing promotions of clinical trials by various governing agencies of
several countries are contributing to the growth of the market. Moreover, the extensive research and development
(R&D) activities conducted by key players regarding stem cell therapy are providing an impetus to the market. In
addition to this, the introduction of advanced cell-based therapies, such as direct cell reprogramming for neuronal
tissue replacement, skin rejuvenation and tendon regeneration therapies, is creating a positive market outlook.
Furthermore, continual technological advancements in the healthcare infrastructure are acting as another significant
growth-inducing factor. Some of the other factors contributing to the market growth include the escalating demand
for regenerative drugs and a considerable increase in medical expenditure. On account of the aforementioned factors,
the market is anticipated to reach a value of US$ 32.1 Billion by 2028, exhibiting a CAGR of 17.5% during 2023-2028.
Looking forward, the market value is projected to reach a strong growth during the forecast period
(2023-2028).
6. Report Description
Report Description and Highlights
• Dermatology
• Others
Breakup by End User:
• Hospitals and Clinics
• Academic and Research Institutes
Breakup by Region:
• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
7. Report Description
Report Description and Highlights
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
8. Competitive Landscape with Key Players:
• AlloSource
• Anterogen Co. Ltd.
• Cells for Cells
• Holostem Terapie Avanzate S.r.l.
• JCR Pharmaceuticals
• Kolon TissueGene Inc.
• MEDIPOST
• Mesoblast Limited
• NuVasive
• Stemedica Cell Technologies Inc.
• Stempeutics Research Pvt. Ltd
• Vericel Corporation
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/cell-therapy-market
Report Description
Report Description and Highlights
9. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients
10. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients